Navigation Links
Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs
Date:9/28/2007

e on what we believe is most critical to our future success -- building and advancing our pipeline."

Idenix currently has a non-nucleoside reverse transcriptase inhibitor (NNRTI), IDX899, for the treatment of HIV-1 that is being evaluated in phase I/II clinical testing. The company also has a comprehensive HCV discovery effort, comprised of a next-generation nucleoside polymerase inhibitor program, including IDX102 and IDX184, which are currently being evaluated in advanced preclinical testing, and HCV non-nucleoside polymerase inhibitor and HCV protease inhibitor programs.

As a result of this restructuring, Idenix will incur between $5 million and $10 million in charges, primarily associated with one-time employee severance benefits and the write-off of certain assets. The company continues to expect to end 2007 with between $100 million and $110 million of cash, cash equivalents and marketable securities. Idenix estimates that this restructuring will result in savings of $40 million to $45 million on an annual basis.

"We have taken the steps necessary to streamline our organization and significantly reduce our expenses, while continuing to maintain the strength of our balance sheet," said Ronald Renaud, Jr., chief financial officer of Idenix. "We believe that we are now well-positioned to fund the advancement of our HIV and HCV discovery and development programs through 2009."

About Idenix/Novartis Collaboration

Idenix and Novartis Pharma AG established a collaboration in May 2003, at which point Novartis became a majority shareholder in Idenix. Currently, Novartis owns 56% of Idenix and has first right of refusal to Idenix's pipeline.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caus
'/>"/>

SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Front-face detection for high-concentrate, opaque or solid sample
4. Concentrated solar energy project wins Innovation Days prizes
5. Wisconsin stands at the center of scientific efforts to avert flu epidemics
6. Thompsons HHS legacy will include efforts to combat disease in Africa
7. Efforts to avoid friendly fire spawned ancestor of todays RFID
8. Manufacturing group says efforts led to big improvements
9. Madison grid computing efforts attack big research questions
10. Californian stem-cell efforts get new rules, attract lawsuits
11. Tech Council passes E-Learning efforts for Northern Wisconsin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/14/2014)... protein functions in a wide variety of ways, including ... protein can take on another form and perform no ... fold wrongly can cause serious diseases such as Alzheimer,s, ... have a tendency to "infect" other molecules of the ... or plaques. These amyloids can damage cells and tissues ...
(Date:9/12/2014)... Switching the polarity of a magnet using an ... a working principle of the next-generation technology for ... candidates for the MEM effect, due to the ... other hand, the coexistence of spontaneous electric and ... hinders the application potential of the MEM effect. ...
(Date:9/12/2014)... 2014 Research and Markets has ... Photoresist Industry Report 2014" report to their offering. ... Report 2014 is a professional and in-depth study on ... industry . The report provides a basic ... industry chain structure. The dry film photoresist market analysis ...
(Date:9/12/2014)... NM (PRWEB) September 12, 2014 Sandia ... an exclusive option agreement with STC.UNM (STC) for a ... Mexico (UNM) in Albuquerque, New Mexico, and Queen Mary ... of technologies, called the Recombinant Fluorescent Antibody Technology Platform ... Department of Internal Medicine and Dr. Angray Kang from ...
Breaking Biology Technology:Measuring modified protein structures 2Measuring modified protein structures 3Global Dry Film Photoresist Industry Report 2014 2Sandia Biotech and STC.UNM Announce Option Agreement to License Novel Recombinant Antibody Technology 2Sandia Biotech and STC.UNM Announce Option Agreement to License Novel Recombinant Antibody Technology 3Sandia Biotech and STC.UNM Announce Option Agreement to License Novel Recombinant Antibody Technology 4
... the casual observer, responders contained the recent E. coli ... health professionals, the automated system used to identify the ... improvement. , ,Still, information technology played a key role ... and it will play an even greater role in ...
... about your firm? Slow? Fast? Lightning Speed? Not sure? , ... yet to adopt a wiki. A wiki, you ask, what's that? ... Today, it has come to mean a collaborative and group editable ... 2.0 that encourage conversations and draw on the power of social ...
... of change sparked by the information technology industry gives ... business challenge, but has IT really come through for ... recent Wisconsin technology conference, the results are mixed but ... Systems , brought together more than 300 corporate clients ...
Cached Biology Technology:Technology played key role in E. coli alerts 2Technology played key role in E. coli alerts 3Technology played key role in E. coli alerts 4Joining the wiki wacki world 2Joining the wiki wacki world 3Joining the wiki wacki world 4Joining the wiki wacki world 5Are businesses getting what they need from IT? 2Are businesses getting what they need from IT? 3
(Date:9/15/2014)... This news release is available in German . ... of a cell is straightforward: it doubles, divides in ... it has been long assumed that cells of the ... divide symmetrically. Silvia Bulgheresi,s team, University of Vienna, revealed ... long to be perceivable by the naked eye. These ...
(Date:9/15/2014)... in our cells cooperate with one another. But, it ... of different proteins find the correct dancing partners as ... and nervous system. A recent breakthrough at the University ... door and provided a look at the once obscure ... Jens Jrgen Led of the University of Copenhagen,s Department ...
(Date:9/15/2014)... tropical rainforest teeming with life it,s not what comes ... the first time evidence of Doncaster,s 310-million-year-old past, including a ... mining tip. , Some of the fossilised plants and creatures ... the egg case, several horseshoe crabs and some previously unrecorded ... preserved in rocks that formed within the coal and shale ...
Breaking Biology News(10 mins):Think big! Bacteria breach cell division size limit 2Protein courtship revealed through chemist's lens 2Protein courtship revealed through chemist's lens 3'Jaws' lived in Doncaster 2
... University researcher is studying whether the most popular ... in users. There is accumulating evidence that ... including muscle weakness, fatigue and deterioration ... radiology and osteopathic manipulative medicine at MSU. ...
... by a team of scientists using optical probes means ... now be seen in a completely different light. ... working with experts from Glasgow University, and a team ... the way that light was emitted by optical probes ...
... worldwide decline in the number of bees and other ... yields, according to the results of an international study ... journal, Current Biology . , Co-author, CSIRO ... detected warning signs that demand for pollinators is still ...
Cached Biology News:MSU researcher studies ties between cholesterol drugs, muscle problems 2Luminescence shines new light on proteins 2Pollinator decline not reducing crop yields just yet 2
Modified and insect cell culture tested....
BD BaculoGold Max-XP Insect Cell Medium 1 Liter...
Mycoplasma and virus tested...
Bethyl Laboratories Ready-To-Use IHC Bluing Reagent is used following IHC hematoxylin counterstaining with immunohistochemical procedures. Shelf-Life: 1 year from date of receipt...
Biology Products: